Diabetes Accessories
- A1c kits
- Adhesives/Creams
- Awareness Products
- Bags
- Books
- Clothing
- Diabetes Socks
- Emergency Kits
- Glucose Tablets/Drinks
- Injection Aids
- Insulin Coolers
- Jewelry
- Ketostix
- Log Books
- Magnifying Aids
- Meter Cases
- Nutritional Scales
- Other
- Pill Boxes
- Portable Fridges
- Portion Control Containers
- Pump Packs/Pouches
- Sharps Containers
- Syringe Holders
- Water proof pump cases
- Waterproof Insulin Pump Cases
General Diabetes Information
- Advocacy
- Associations
- Continuous Glucose Monitor Companies
- Dictionaries
- Emergency Information
- Home Delivery Services
- Insulin Pump Companies
- Insurance
- Organizations
- Pharmaceutical Companies
- Traveling
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- DC
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Lousiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Puerto Rico
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virgin Islands
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
stock market (3)
-
The Insulin to Lose Weight
Insulin gets a black eye when it comes to weight loss. But a new insulin analogue out of Eli Lilly is showing the opposite side effect on people who use insulin to treat their diabetes. The study was published in Diabetes, Obesity, & Metabolism. In phase 2 studies, the basal insulin was shown to help […]
more... -
DiaPep277 Slows the Antibody Attack in T1D
DiaPep277 is an innovative treatment for Type 1 diabetes (T1D) made by AndromedA Biotech. The company has successful results from a Phase III clinical study demonstrating DidPep277 arresting the immune attack causing T1D. DiaPep277 impairs the immune systems from detecting and destroying beta cells. The ideal candidate for use of DiaPep277 is a newly diagnosed […]
more... -
‘Foolish’ Five Companies to Dominate in Diabetes
According to the Motley Fool, a financial-services company with the sole purpose to help the world invest (better), 8% of the U.S. population is affected by diabetes. The top companies poised to profit from this experience are: Novo Nordisk (NYSE: NVO), Snofi (NYSC: SNY), MannKind (Nasdaq: MNKD), Bristol-Myers Squibb (NYSE: BMY), and AstraZeneca (NYSE: AZN). […]
more...
Bloggers
Media